Results of COLUMBUS Part 2: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) versus ENCO in BRAF-mutant melanoma
2017-09-01
SCID: 54.1/yztca7m7
Publication Details
Publication Date
2017-09-01
Journal
Publisher
ISSN
Access Type
Author Information
Download PDF